Clinical Trials Directory

Trials / Unknown

UnknownNCT01962181

Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment

Identifying Characteristic Signature of Brain Activity of Electroencephalogram Records in Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

In this study we try to identify the signature of brain activity in the EEG of attention deficit disorder (ADHD) patients compared to healthy subjects under different doses of Ritalin (methylphenidate) treatment.

Detailed description

In this study we try to identify the signature of brain activity in the EEG of attention deficit disorder (ADHD) patients compared to healthy subjects under different doses of Ritalin (methylphenidate) treatment. All subjects will undergo 1-4 EEG sessions. In each session we will use a different dose of Ritalin or placebo. A detailed neuropsychological tests will be done during the EEG recording. A powerful machine-learning techniques will be used in order to find a specific signature of ADHD and Ritalin treatment in the EEG recording.

Conditions

Interventions

TypeNameDescription
DRUGRitalinPatients with ADHD and healthy subjects will be examined under Ritalin or placebo
DRUGPlacebo

Timeline

Start date
2013-10-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2013-10-14
Last updated
2013-10-14

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01962181. Inclusion in this directory is not an endorsement.

Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment (NCT01962181) · Clinical Trials Directory